Latest Regulatory News

NoviqTech Limited has announced a non-renounceable pro-rata entitlement issue of new options aiming to raise approximately $251,000. Eligible shareholders can subscribe at a low issue price, with options exercisable over three years.

Blackstone Minerals Limited has requested an immediate voluntary suspension of its shares as it finalises a proposed merger, signaling a significant strategic shift for the mining company.

Brookfield Capital Partners has submitted a non-binding proposal to acquire Insignia Financial at A$4.60 per share, matching rival offers and setting the stage for a competitive bidding process.

VRX Silica Limited's Arrowsmith North silica sand project faces a formal appeal from the Conservation Council of WA, challenging the recent environmental approval recommendation. The company is preparing its response while continuing to advance parallel permitting processes.

Hartshead Resources has submitted a revised development report to the NSTA, unveiling a superior gas export route through CalEnergy's Saturn Banks pipeline that promises reduced costs and faster production.

New Age Exploration has completed a critical Aboriginal Cultural Heritage Survey at its Wagyu Gold Project, unlocking expanded access to high-priority gold targets ahead of a planned Reverse Circulation drilling program in March 2025.

Australian Rare Earths Limited (AR3) has obtained South Australian Government approval to expand its Overland Uranium Project, gaining rights over an additional ~1,000km² and greenlighting immediate drilling on high-potential targets.

Solstice Minerals has secured the advanced Nanadie Copper-Gold Project in Western Australia, acquiring a JORC-compliant Inferred Mineral Resource of 40.4Mt at 0.4% copper and 0.1g/t gold. The acquisition positions Solstice for growth amid strong long-term copper demand.

Vanadium Resources Limited (ASX: VR8) has voluntarily suspended trading of its shares pending a significant announcement on funding arrangements, signaling a pivotal moment for the company’s financial trajectory.

Fortescue Ltd has crossed the 75% ownership threshold in Red Hawk Mining, prompting an increase in its takeover offer price from A$1.05 to A$1.20 per share ahead of the March 3 closing date.

Neurizon Therapeutics has been granted a pivotal US patent for its lead drug candidate NUZ-001, extending protection until 2039 and enhancing its commercial and clinical positioning in neurodegenerative disease treatment.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.